MedPath
NMPA Approval

Ganaxolone Oral Suspension

国药准字HJ20240071

July 9, 2024

Drug Information

加那索龙口服混悬剂

泽元安

口服混悬剂

110ml:5.5g

化学药品

July 9, 2024

July 8, 2029

Company Information

Applicant Company

5 Radnor Corporate Center, 100 Matsonford Road, Suite 500, Radnor, PA 19087 United States of America

Manufacturing Company

altasciences cdmo philadelphia, llc

1510 Delp Drive, Harleysville, PA 19438 United States of America

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

加那索龙口服混悬剂 - NMPA 批准文号 | MedPath